Cover Image
Market Research Report

Patient Derived Xenograft/PDX Models

Published by Global Industry Analysts, Inc. Product code 913474
Published Content info 129 Pages
Delivery time: 1-2 business days
Price
Back to Top
Patient Derived Xenograft/PDX Models
Published: October 1, 2019 Content info: 129 Pages
Description

Patient Derived Xenograft/PDX Models market worldwide is projected to grow by US$176.1 Million, driven by a compounded growth of 17.1%. Mouse, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$178 Million by the year 2025, Mouse will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 18.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$6.9 Million to the region's size and clout in the next 5 to 6 years. Over US$8.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Mouse will reach a market size of US$12.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.8% over the next couple of years and add approximately US$31 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Champions Oncology, Inc.; Charles River Laboratories International, Inc.; Crown Bioscience, Inc.; Epo Berlin-Buch GmbH; Hera BioLabs; Oncodesign; Pharmatest Services Ltd.; The Jackson Laboratory; Urolead SAS; WuXi AppTec; Xentech

Table of Contents
Product Code: MCP13873

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Patient Derived Xenograft/PDX Models Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Patient Derived Xenograft/PDX Models Global Market Estimates and Forecasts in US$ by Region/Country: 2018-2025
  • TABLE 2: Patient Derived Xenograft/PDX Models Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
  • TABLE 3: Pre-Clinical Drug Development (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2018-2025
  • TABLE 4: Pre-Clinical Drug Development (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
  • TABLE 5: Basic Cancer Research (Application) Demand Potential Worldwide in US$ by Region/Country: 2018-2025
  • TABLE 6: Basic Cancer Research (Application) Share Breakdown Review by Region/Country: 2019 VS 2025
  • TABLE 7: Mouse (Type) World Market by Region/Country in US$: 2018 to 2025
  • TABLE 8: Mouse (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
  • TABLE 9: Rat (Type) Potential Growth Markets Worldwide in US$: 2018 to 2025
  • TABLE 10: Rat (Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
  • TABLE 11: Pharma & Biotech (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2018-2025
  • TABLE 12: Pharma & Biotech (End-Use) Distribution of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 13: CRO (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2018 through 2025
  • TABLE 14: CRO (End-Use) Global Market Share Distribution by Region/Country for 2019 and 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Patient Derived Xenograft/PDX Models Market Share (in %) by Company: 2019 & 2025
    • TABLE 15: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by Application: 2018 to 2025
    • TABLE 16: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by Application: 2019 VS 2025
    • TABLE 17: United States Patient Derived Xenograft/PDX Models Market Estimates and Projections in US$ by Type: 2018 to 2025
    • TABLE 18: United States Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
    • TABLE 19: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by End-Use: 2018 to 2025
    • TABLE 20: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by End-Use: 2019 VS 2025
  • CANADA
    • TABLE 21: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2018 to 2025
    • TABLE 22: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
    • TABLE 23: Canadian Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018 to 2025
    • TABLE 24: Patient Derived Xenograft/PDX Models Market in Canada: Percentage Share Breakdown of Sales by Type for 2019 and 2025
    • TABLE 25: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2018 to 2025
    • TABLE 26: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
  • JAPAN
    • TABLE 27: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
    • TABLE 28: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by Application: 2019 VS 2025
    • TABLE 29: Japanese Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2018-2025
    • TABLE 30: Japanese Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
    • TABLE 31: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
    • TABLE 32: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by End-Use: 2019 VS 2025
  • CHINA
    • TABLE 33: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
    • TABLE 34: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2019 VS 2025
    • TABLE 35: Chinese Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2018-2025
    • TABLE 36: Chinese Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2019 and 2025
    • TABLE 37: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
    • TABLE 38: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Patient Derived Xenograft/PDX Models Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 39: European Patient Derived Xenograft/PDX Models Market Demand Scenario in US$ by Region/Country: 2018-2025
    • TABLE 40: European Patient Derived Xenograft/PDX Models Market Share Shift by Region/Country: 2019 VS 2025
    • TABLE 41: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2018-2025
    • TABLE 42: European Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
    • TABLE 43: European Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018-2025
    • TABLE 44: European Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
    • TABLE 45: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2018-2025
    • TABLE 46: European Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
  • FRANCE
    • TABLE 47: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by Application: 2018-2025
    • TABLE 48: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    • TABLE 49: Patient Derived Xenograft/PDX Models Market in France by Type: Estimates and Projections in US$ for the Period 2018-2025
    • TABLE 50: French Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
    • TABLE 51: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by End-Use: 2018-2025
    • TABLE 52: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025
  • GERMANY
    • TABLE 53: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2018-2025
    • TABLE 54: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by Application: 2019 VS 2025
    • TABLE 55: Patient Derived Xenograft/PDX Models Market in Germany: Recent Past, Current and Future Analysis in US$ by Type for the Period 2018-2025
    • TABLE 56: German Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
    • TABLE 57: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2018-2025
    • TABLE 58: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by End-Use: 2019 VS 2025
  • ITALY
    • TABLE 59: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
    • TABLE 60: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2019 VS 2025
    • TABLE 61: Italian Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2018-2025
    • TABLE 62: Italian Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2019 and 2025
    • TABLE 63: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
    • TABLE 64: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 65: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
    • TABLE 66: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by Application: 2019 VS 2025
    • TABLE 67: United Kingdom Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2018-2025
    • TABLE 68: United Kingdom Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
    • TABLE 69: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
    • TABLE 70: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by End-Use: 2019 VS 2025
  • REST OF EUROPE
    • TABLE 71: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2018-2025
    • TABLE 72: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
    • TABLE 73: Rest of Europe Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018-2025
    • TABLE 74: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
    • TABLE 75: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2018-2025
    • TABLE 76: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 77: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2018-2025
    • TABLE 78: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    • TABLE 79: Patient Derived Xenograft/PDX Models Market in Asia-Pacific by Type: Estimates and Projections in US$ for the Period 2018-2025
    • TABLE 80: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
    • TABLE 81: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2018-2025
    • TABLE 82: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025
  • REST OF WORLD
    • TABLE 83: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2018 to 2025
    • TABLE 84: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
    • TABLE 85: Rest of World Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018 to 2025
    • TABLE 86: Patient Derived Xenograft/PDX Models Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2019 and 2025
    • TABLE 87: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2018 to 2025
    • TABLE 88: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025

IV. COMPETITION

  • CHAMPIONS ONCOLOGY
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CROWN BIOSCIENCE
  • EPO BERLIN-BUCH GMBH
  • HERA BIOLABS
  • ONCODESIGN
  • PHARMATEST SERVICES LTD.
  • THE JACKSON LABORATORY
  • UROLEAD SAS
  • WUXI APPTEC
  • XENTECH

V. CURATED RESEARCH

Back to Top